Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Reduced-intensity dosing of talquetamab may improve tolerability without compromising efficacy among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback